Add BrightSurf on Google Email

Johns Hopkins Medicine


Key to lung cancer chemo resistance revealed

Researchers at Johns Hopkins have found that lung cancer cells exploit the NRF2 gene to detoxify chemicals, including chemotherapy agents, rendering them ineffective. This discovery may lead to new treatment strategies by blocking NRF2 activity, potentially improving standard chemotherapy drug efficacy.

SourceJohns Hopkins Medicine·JournalPLOS Medicine·DateOct 10, 2006

Bacteria get off easy in sinus infections

In a study led by Johns Hopkins Medicine, researchers discovered that patients with chronic sinusitis who failed to respond to treatment had severely decreased immune function and lower production of key proteins. The findings suggest new treatment targets for this condition affecting an estimated 32 million Americans.

Anemia affects body ... and maybe the mind

Researchers at Johns Hopkins Medicine found a link between mild anemia and impaired thinking in elderly women. Those with anemia were four to five times more likely to perform poorly on executive function tests, compared to those with normal blood hemoglobin.

SourceJohns Hopkins Medicine·JournalJournal of the American Geriatrics Society·DateSep 13, 2006

Genome code cracked for breast and colon cancers

Researchers at Johns Hopkins Kimmel Cancer Center have identified close to 200 mutated genes linked to breast and colon cancer. The genetic code reveals distinct pathways for the development of each cancer type, with some genes crucial for tumor formation. The findings provide a foundation for future comprehensive genetic studies.

SourceJohns Hopkins Medicine·JournalScience·DateSep 7, 2006

Closing in on lethal heart rhythm in young athletes

Researchers at Johns Hopkins Medicine have identified four mutations in the Desmoglein-2 gene as a significant contributor to arrhythmogenic right ventricular dysplasia (ARVD), a condition that causes sudden cardiac death in young athletes. The findings should increase the accuracy of tests to identify those at risk for ARVD.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Human Genetics·DateSep 7, 2006

Antioxidants may slow vision loss

Scientists at Johns Hopkins have successfully blocked the advance of retinal degeneration in mice with antioxidants, including vitamin E and alpha-lipoic acid. The study found that high oxygen levels in the retina kill cone photoreceptors, which are critical to central vision.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJul 19, 2006

Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience

Johns Hopkins researchers show that psilocybin can induce mystical/spiritual experiences descriptively identical to those reported for centuries. Subjects who underwent the experience reported positive changes in behavior and attitude, lasting several months. The study's results have significant implications for our understanding of hu...

SourceJohns Hopkins Medicine·JournalPsychopharmacology·DateJul 11, 2006